Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development

Sexual Development

Volumn 2, Issue 4-5, 2008, Pages 200-209

  Lin, L ^a   Achermann, J C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

46,XY DSD; Gonad; Gonadal dysgenesis; NR5A1; Nuclear receptor; Pituitary; Steroidogenesis; Steroidogenic factor 1

Indexed keywords

CELL NUCLEUS RECEPTOR; PROTEIN AD4BP; PROTEIN NR5A1; STEROIDOGENIC FACTOR 1; UNCLASSIFIED DRUG;

ADRENAL FUNCTION; ADRENAL INSUFFICIENCY; CHROMOSOME DISORDER; CONFERENCE PAPER; DEVELOPMENTAL DISORDER; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENE STRUCTURE; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; TESTIS DEVELOPMENT; TESTIS DISEASE;

ANIMALS; HUMANS; MALE; MICE; MUTATION; SEX DIFFERENTIATION DISORDERS; STEROIDOGENIC FACTOR 1; TESTIS;

MUS;

EID: 55749088979     PISSN: 16615425     EISSN: 16615433     Source Type: Journal    
DOI: 10.1159/000152036     Document Type: Conference Paper

References (73)

1. Achermann JC, Ito M, Ito M, Hindmarsh PC, Jameson JL: A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 22:125-126 (1999).
2. Achermann JC, Ozisik G, Ito M, Orun UA, Harmanci K, et al: Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J Clin Endocrinol Metab 87:1829-1833 (2002).
3. Biason-Lauber A, Schoenle EJ: Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet 67:1563-1568 (2000).
4. Bland ML, Fowkes RC, Ingraham HA: Differential requirement for steroidogenic factor-1 gene dosage in adrenal development versus endocrine function. Mol Endocrinol 18:941-952 (2004).
5. Cammas FM, Pullinger GD, Barker S, Clark AJ: The mouse adrenocorticotropin receptor gene: cloning and characterization of its promoter and evidence for a role for the orphan nuclear receptor steroidogenic factor 1. Mol Endocrinol 11:867-876 (1997).
6. Caron KM, Ikeda Y, Soo SC, Stocco DM, Parker KL, Clark BJ: Characterization of the promoter region of the mouse gene encoding the steroidogenic acute regulatory protein. Mol Endocrinol 11:138-147 (1997).
7. Correa RV, Domenice S, Bingham NC, Billerbeck AE, Rainey WE, et al: A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency. J Clin Endocrinol Metab 89:1767-1772 (2004).
8. Coutant R, Mallet D, Lahlou N, Bouhours-Nouet N, Guichet A, et al: Heterozygous mutation of steroidogenic factor-1 in 46,XY subjects may mimic partial androgen insensitivity syndrome. J Clin Endocrinol Metab 92:2868-2873 (2007).
9. Del Tredici AL, Andersen CB, Currier EA, Ohrmund SR, Fairbain LC, et al: Identification of the first synthetic steroidogenic factor 1 inverse agonists: pharmacological modulation of steroidogenic enzymes. Mol Pharmacol 73:900-908 (2008).
10. Desclozeaux M, Krylova IN, Horn F, Fletterick RJ, Ingraham HA: Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1. Mol Cell Biol 22:7193-7203 (2002).
11. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 240:889-895 (1988).
12. Figueiredo BC, Cavalli LR, Pianovski MA, Lalli E, Sandrini R, et al: Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors. J Clin Endocrinol Metab 90:615-619 (2005).
13. Hammer GD, Krylova I, Zhang Y, Darimont BD, Simpson K, et al: Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol Cell 3:521-526 (1999).
14. Hanley NA, Ball SG, Clement-Jones M, Hagan DM, Strachan T, et al: Expression of steroidogenic factor 1 and Wilms' tumour 1 during early human gonadal development and sex determination. Mech Dev 87:175-180 (1999).
15. Hasegawa T, Fukami M, Sato N, Katsumata N, Sasaki G, et al: Testicular dysgenesis without adrenal insufficiency in a 46,XY patient with a heterozygous inactive mutation of steroidogenic factor-1. J Clin Endocrinol Metab 89:5930-5935 (2004).
16. Honda S, Morohashi K, Nomura M, Takeya H, Kitajima M, Omura T: Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J Biol Chem 268:7494-7502 (1993).
17. Ikeda Y, Shen WH, Ingraham HA, Parker KL: Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol Endocrinol 8:654-662 (1994).
18. Ito M, Yu R, Jameson JL: DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol 17:1476-1483 (1997).
19. Ito M, Yu RN, Jameson JL: Steroidogenic factor-1 contains a carboxy-terminal transcriptional activation domain that interacts with steroid receptor coactivator-1. Mol Endocrinol 12:290-301 (1998).
20. Ito M, Achermann JC, Jameson JL: A naturally occurring steroidogenic factor-1 mutation exhibits differential binding and activation of target genes. J Biol Chem 275:31708-31714 (2000).
21. Jameson JL: Of mice and men: The tale of steroidogenic factor-1. J Clin Endocrinol Metab 89:5927-5929 (2004).
22. Katoh-Fukui Y, Owaki A, Toyama Y, Kusaka M, Shinohara Y, et al: Mouse Polycomb M33 is required for splenic vascular and adrenal gland formation through regulating Ad4BP/SF1 expression. Blood 106:1612-1620 (2005).
23. Köhler B, Lin L, Ferraz-de-Souza B, Wieacker P, Heidemann P, et al: Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency. Hum Mutat 29:59-64 (2008).
24. Komatsu T, Mizusaki H, Mukai T, Ogawa H, Baba D, et al: Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/ SF-1 and Sox9. Mol Endocrinol 18:2451-2462 (2004).
25. Krylova IN, Sablin EP, Moore J, Xu RX, Waitt GM, et al: Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120:343-355 (2005).
26. Kurrasch DM, Cheung CC, Lee FY, Tran PV, Hata K, Ingraham HA: The neonatal ventromedial hypothalamus transcriptome reveals novel markers with spatially distinct patterning. J Neurosci 27:13624-13634 (2007).
27. Lala DS, Rice DA, Parker KL: Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol Endocrinol 6:1249-1258 (1992).
28. Lee MB, Lebedeva LA, Suzawa M, Wadekar SA, Desclozeaux M, Ingraham HA: The DEADbox protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification. Mol Cell Biol 25:1879-1890 (2005).
29. Lewis AE, Rusten M, Hoivik EA, Vikse EL, Hansson ML, et al: Phosphorylation of steroidogenic factor 1 is mediated by cyclin-dependent kinase 7. Mol Endocrinol 22:91-104 (2008).
30. Li D, Urs AN, Allegood J, Leon A, Merrill AH Jr, Sewer MB: Cyclic AMP-stimulated interaction between steroidogenic factor 1 and diacylglycerol kinase theta facilitates induction of CYP17. Mol Cell Biol 27:6669-6685 (2007).
31. Li Y, Choi M, Cavey G, Daugherty J, Suino K, et al: Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Mol Cell 17:491-502 (2005).
32. Lin L, Gu WX, Ozisik G, To WS, Owen CJ, et al: Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience. J Clin Endocrinol Metab 91:3048-3054 (2006).
33. Lin L, Philibert P, Ferraz-de-Souza B, Kelberman D, Homfray T, et al: Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. J Clin Endocrinol Metab 92:991-999 (2007).
34. Little TH, Zhang Y, Matulis CK, Weck J, Zhang Z, et al: Sequence-specific deoxyribonucleic acid (DNA) recognition by steroidogenic factor 1: a helix at the carboxy terminus of the DNA binding domain is necessary for complex stability. Mol Endocrinol 20:831-843 (2006).
35. Luo X, Ikeda Y, Parker KL: A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77:481-490 (1994).
36. Majdic G, Young M, Gomez-Sanchez E, Anderson P, Szczepaniak LS, et al: Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity. Endocrinology 143:607-614 (2002).
37. Mallet D, Bretones P, Michel-Calemard L, Dijoud F, David M, Morel Y: Gonadal dysgenesis without adrenal insufficiency in a 46, XY patient heterozygous for the nonsense C16X mutation: a case of SF1 haploinsufficiency. J Clin Endocrinol Metab 89:4829-4832 (2004).
38. Morohashi K, Honda S, Inomata Y, Handa H, Omura T: A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. J Biol Chem 267:17913-17919 (1992).
39. Murayama C, Miyazaki H, Miyamoto A, Shimizu T: Involvement of Ad4BP/SF-1, DAX-1, and COUP-TFII transcription factor on steroid production and luteinization in ovarian theca cells. Mol Cell Biochem 314:51-58 (2008).
40. Nef S, Schaad O, Stallings NR, Cederroth CR, Pitetti JL, et al: Gene expression during sex determination reveals a robust female genetic program at the onset of ovarian development. Dev Biol 287:361-377 (2005).
41. Oba K, Yanase T, Nomura M, Morohashi K, Takayanagi R, Nawata H: Structural characterization of human Ad4bp (SF-1) gene. Biochem Biophys Res Commun 226:261-267 (1996).
42. Park YY, Park KC, Shong M, Lee SJ, Lee YH, Choi HS: EID-1 interacts with orphan nuclear receptor SF-1 and represses its transactivation. Mol Cells 24:372-377 (2007).
43. Philibert P, Zenaty D, Lin L, Soskin S, Audran F, et al: Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study. Hum Reprod 22:3255-3261 (2007).
44. Ramayya MS, Zhou J, Kino T, Segars JH, Bondy CA, Chrousos GP: Steroidogenic factor 1 messenger ribonucleic acid expression in steroidogenic and nonsteroidogenic human tissues: Northern blot and in situ hybridization studies. J Clin Endocrinol Metab 82:1799-1806 (1997).
45. Reuter AL, Goji K, Bingham NC, Matsuo M, Parker KL: A novel mutation in the accessory DNA-binding domain of human steroidogenic factor 1 causes XY gonadal dysgenesis without adrenal insufficiency. Eur J Endocrinol 157:233-238 (2007).
46. Rice DA, Mouw AR, Bogerd AM, Parker KL: A shared promoter element regulates the expression of three steroidogenic enzymes. Mol Endocrinol 5:1552-1561 (1991).
47. Sadovsky Y, Crawford PA, Woodson KG, Polish JA, Clements MA, et al: Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc Natl Acad Sci USA 92:10939-10943 (1995).
48. Schlaubitz S, Yatsenko SA, Smith LD, Keller KL, Vissers LE, et al: Ovotestes and XY sex reversal in a female with an interstitial 9q33.3-q34.1 deletion encompassing NR5A1 and LMX1B causing features of Genitopatellar syndrome. Am J Med Genet A 143:1071-1081 (2007).
49. Sekido R, Lovell-Badge R: Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 453:930-934 (2008).
50. Shima Y, Zubair M, Komatsu T, Oka S, Yokoyama C, et al: Pituitary homeobox 2 regulates Adrenal4 binding protein/steroidogenic factor-1 gene transcription in the pituitary gonadotrope through interaction with the intronic enhancer. Mol Endocrinol 22:1633-1646 (2008).
51. Shinoda K, Lei H, Yoshii H, Nomura M, Nagano M, et al: Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice. Dev Dyn 204:22-29 (1995).
52. Sugawara T, Kiriakidou M, McAllister JM, Kallen CB, Strauss JF 3rd: Multiple steroidogenic factor 1 binding elements in the human steroidogenic acute regulatory protein gene 5′-flanking region are required for maximal promoter activity and cyclic AMP responsiveness. Biochemistry 36:7249-7255 (1997).
53. Swift S, Ashworth A: The mouse Ftzf1 gene required for gonadal and adrenal development maps to mouse chromosome 2. Genomics 28:609-610 (1995).
54. Taketo M, Parker KL, Howard TA, Tsukiyama T, Wong M, et al: Homologs of Drosophila Fushi-Tarazu factor 1 map to mouse chromosome 2 and human chromosome 9q33. Genomics 25:565-567 (1995).
55. Tremblay JJ, Viger RS: A mutated form of steroidogenic factor 1 (SF-1 G35E) that causes sex reversal in humans fails to synergize with transcription factor GATA-4. J Biol Chem 278:42637-42642 (2003).
56. Ueda H, Sonoda S, Brown JL, Scott MP, Wu C: A sequence-specific DNA-binding protein that activates fushi tarazu segmentation gene expression. Genes Dev 4:624-635 (1990).
57. Ueda H, Sun GC, Murata T, Hirose S: A novel DNA-binding motif abuts the zinc finger domain of insect nuclear hormone receptor FTZ-F1 and mouse embryonal long terminal repeat-binding protein. Mol Cell Biol 12:5667-5672 (1992).
58. Utsunomiya H, Cheng YH, Lin Z, Reierstad S, Yin P, et al: Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis. Mol Endocrinol 22:904-914 (2008).
59. Val P, Martinez-Barbera JP, Swain A: Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage. Development 134:2349-2358 (2007).
60. Wada Y, Okada M, Hasegawa T, Ogata T: Association of severe micropenis with Gly146Ala polymorphism in the gene for steroidogenic factor-1. Endocr J 52:445-448 (2005).
61. Wada Y, Okada M, Fukami M, Sasagawa I, Ogata T: Association of cryptorchidism with Gly146Ala polymorphism in the gene for steroidogenic factor-1. Fertil Steril 85:787-790 (2006).
62. Wang DS, Kobayashi T, Zhou LY, Paul-Prasanth B, Ijiri S, et al: Foxl2 up-regulates aromatase gene transcription in a female-specific manner by binding to the promoter as well as interacting with ad4 binding protein/steroidogenic factor 1. Mol Endocrinol 21:712-725 (2007).
63. Wang W, Zhang C, Marimuthu A, Krupka HI, Tabrizizad M, et al: The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1. Proc Natl Acad Sci USA 102:7505-7510 (2005).
64. Wang ZJ, Jeffs B, Ito M, Achermann JC, Yu RN, et al: Aromatase (Cyp19) expression is upregulated by targeted disruption of Dax1. Proc Natl Acad Sci USA 98:7988-7993 (2001).
65. Whitby RJ, Dixon S, Maloney PR, Delerive P, Goodwin BJ, et al: Identification of small molecule agonists of the orphan nuclear receptors liver receptor homolog-1 and steroidogenic factor-1. J Med Chem 49:6652-6655 (2006).
66. Wilhelm D, Englert C: The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1. Genes Dev 16:1839-1851 (2002).
67. Wilson TE, Paulsen RE, Padgett KA, Milbrandt J: Participation of non-zinc finger residues in DNA binding by two nuclear orphan receptors. Science 256:107-110 (1992).
68. Wong M, Ramayya MS, Chrousos GP, Driggers PH, Parker KL: Cloning and sequence analysis of the human gene encoding steroidogenic factor 1. J Mol Endocrinol 17:139-147 (1996).
69. WuQiang F, Yanase T, Wei L, Oba K, Nomura M, et al: Functional characterization of a new human Ad4BP/SF-1 variation, G146A. Biochem Biophys Res Commun 311:987-994 (2003).
70. Xue Q, Lin Z, Yin P, Milad MP, Cheng YH, Confino E, Reierstad S, Bulun SE: Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5′ CpG island in endometriosis. J Clin Endocrinol Metab 92:3261-3267 (2007).
71. Yu RN, Ito M, Jameson JL: The murine Dax-1 promoter is stimulated by SF-1 (steroidogenic factor-1) and inhibited by COUP-TF (chicken ovalbumin upstream promoter-transcription factor) via a composite nuclear receptor-regulatory element. Mol Endocrinol 12:1010-1022 (1998).
72. Zhao L, Kim KW, Ikeda Y, Anderson KK, Beck L, et al: CNS-Specific knockout of steroidogenic factor 1 results in increased anxiety-like behavior. Mol Endocrinol 22:1403-1415 (2008).
73. Zubair M, Ishihara S, Oka S, Okumura K, Morohashi K: Two-step regulation of Ad4BP/SF-1 gene transcription during fetal adrenal development: initiation by a Hox-Pbx1-Prep1 complex and maintenance via autoregulation by Ad4BP/SF-1. Mol Cell Biol 26:4111-4121 (2006).